Biohaven (BHVN) is scheduled to report Q4 earnings on March 2, 2026. Analysts estimate EPS of $-1.06 and quarterly revenue of $1.54M.
In the most recent quarter (Q3), Biohaven reported EPS of $-1.47, beating estimates of $-1.73 by 0.15%. Revenue came in at $0.00, missing the estimate of $1.86M by 1.00%.
Biohaven has beaten EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, Biohaven has averaged an EPS surprise of 0.10% and a revenue surprise of 1.00%.
Analyze the earnings history of Biohaven using advanced sorting and filters.
The chart below shows Biohaven's reported EPS compared to analyst estimates over recent quarters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-10 | $-1.47 | $-1.73 | 15.0 % |
| Q2 | 2025-08-11 | $-1.63 | $-1.72 | 5.23 % |
| Q1 | 2025-05-12 | $-1.64 | $-1.49 | -10.1 % |
| Q4 | 2025-03-03 | $-1.71 | $-1.56 | -9.62 % |
The chart below shows Biohaven's reported revenue compared to analyst estimates over recent quarters.
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-10 | $0 | $1.86M | -100.0 % |
| Q1 | 2025-05-12 | $0 | $1.39M | -100.0 % |
| Q4 | 2025-03-03 | $0 | $100.00M | -100.0 % |
| Q2 | 2022-08-05 | $215.08M | $212.11M | 1.40 % |
Biohaven (BHVN) is scheduled to report earnings on May 11, 2026. The last reported earnings were for reported on November 10, 2025 for Q3.
The Actual EPS was $-1.47, which beat the estimate of $-1.73.
The Actual Revenue was $0.00, which missed the estimate of $1.86M.